David Wonderling

4.4k citations

47 papers · 3.1k indexed · 1 hit paper · h-index 25

Impact in

Geriatrics and Gerontology top 2%
Economics and Econometrics top 1%
- Health Systems, Economic Evaluations, Quality of Life
- Healthcare Policy and Management

Papers in

Geriatrics and Gerontology 4
- Pharmaceutical Practices and Patient Outcomes 3
Internal Medicine 3

Co-authors: Andrew Briggs Christopher Z. Mooney Richard Grieve Camilla Normand Y Saunders J R Ross Peter J. Edmonds Karen Broadley
Journals: Health Technology Assessment (4 papers)Value in Health (4 papers)BMJ (3 papers)Gastroenterology (3 papers)Health Economics (2 papers)
Partner nations: United Kingdom United States Egypt

In The Last Decade

David Wonderling

47 papers receiving 3.0k citations

Hit Papers

align trajectories log scale

Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation 1997 · 700 citations

Peers

Countries citing papers authored by David Wonderling

Since Specialization

Citations

This map shows the geographic impact of David Wonderling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wonderling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wonderling more than expected).

Fields of papers citing papers by David Wonderling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Wonderling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wonderling. The network helps show where David Wonderling may publish in the future.

Co-authors

The 25 scholars most cited alongside David Wonderling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Wonderling Line = papers co-authored together David Wonderling links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Head injury: assessment and early management—summary of updated NICE guidance BMJ ·Sharangini Rajesh, David Wonderling, Ian Bernstein, Caroline Balson, Fiona Lecky	2023	6
2	Cost Effectiveness of Advanced Pharmacy Services Provided in the Community and Primary Care Settings: A Systematic Review PharmacoEconomics ·Dalia Dawoud, Alex Haines, David Wonderling, Joanna Ashe, Jennifer Hill, Mihir Varia, Philip Dyer, Julian Bion	2019	26
3	Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Cost-Utility Analysis Value in Health ·Dalia Dawoud, Elisabetta Fenu, Bernard Higgins, David Wonderling, Stephanie A. Amiel	2017	6
4	Cost-Effectiveness Analysis of Natriuretic Peptide Testing and Specialist Management in Patients with Suspected Acute Heart Failure Value in Health ·E A Griffin, David Wonderling, Andrew Ludman, Abdallah Al‐Mohammad, Martín Cowie, Suzanna M.C. Hardman, John J.V. McMurray, Jason Kendall, Polly Mitchell, Aminat Shote, Katharina Dworzynski, Jonathan Mant	2017	9
5	Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Systematic Review and Network Meta-Analysis Value in Health ·Dalia Dawoud, Rachel O’Mahony, David Wonderling, Jill Cobb, Bernard Higgins, Stephanie A. Amiel	2017	9
6	The economic burden of stroke care in England, Wales and Northern Ireland: Using a national stroke register to estimate and report patient-level health economic outcomes in stroke European Stroke Journal ·Xu Xiangming, Emma Vestesson, Lizz Paley, Anita Desikan, David Wonderling, Alex Hoffman, Charles Wolfe, Anthony Rudd, Benjamin Bray	2017	85
7	Basal Insulin Regimens: Systematic Review, Network Meta-Analysis, and Cost - Utility Analysis for the National Institute For Health and Care Excellence (Nice) Clinical Guideline on Type 1 Diabetes Mellitus in Adults Value in Health ·Dalia Dawoud, Elisabetta Fenu, David Wonderling, Rachel O’Mahony, N. A. Pursey, Jill Cobb, SA Amiel, Brenda Higgins	2015	1
8	A Cost-effectiveness Analysis of Surgery, Endothermal Ablation, Ultrasound-guided Foam Sclerotherapy and Compression Stockings for Symptomatic Varicose Veins European Journal of Vascular and Endovascular Surgery ·G. Marsden, Mark Perry, Andrew W. Bradbury, N C Hickey, Kate Kelley, Hazel Trender, David Wonderling, Alun H. Davies	2015	32
9	Early identification and management of chronic kidney disease in adults: summary of updated NICE guidance BMJ ·Serena Carville, David Wonderling, P E Stevens, (unknown)	2014	46
10	Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project Health Technology Assessment ·Joanne Lord, Sarah Willis, Julie Eatock, Paul Tappenden, Marta Trapero‐Bertran, Alec Miners, Catriona Crossan, Maggie J Westby, Anastasia Anagnostou, Simon J. E. Taylor, Ifigeneia Mavranezouli, David Wonderling, Priscilla Alderson, Francis Ruiz	2013	46
11	The cost effectiveness of Nucleic Acid Amplification Techniques for the diagnosis of tuberculosis Respiratory Medicine ·Ralph Hughes, David Wonderling, Bernadette Li, Bernard Higgins	2011	29
12	Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study The Lancet ·Kate Lovibond, Sue Jowett, Pelham Barton, Mark J. Caulfield, Carl Heneghan, Richard Hobbs, James Hodgkinson, Jonathan Mant, Una Martin, Bryan Williams, David Wonderling, Richard J. McManus	2011	230
13	Long-term Outcomes of Endoscopic vs Surgical Drainage of the Pancreatic Duct in Patients With Chronic Pancreatitis Gastroenterology ·Djuna L. Cahen, Dirk J. Gouma, Philippe Laramée, Yung Nio, Erik A. Rauws, Marja A. Boermeester, Olivier R. Busch, Paul Fockens, Ernst J. Kuipers, Stephen P. Pereira, David Wonderling, Marcel G.W. Dijkgraaf, Marco J. Bruno	2011	185
14	Journal Club Complementary Medicine Research ·Dieter Melchart, Klaus Linde, Claudia Mandato, Karen J. Sherman, Stefan N. Willich, David Wonderling, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2007	1
15	A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes British Journal of Cancer ·Penelope Hopwood, David Wonderling, Maggie Watson, A. Cull, Fiona Douglas, T Cole, Diana Eccles, J. Gray, Victoria Murday, M Steel, John Burn, Klim McPherson	2004	20
16	Acupuncture of chronic headache disorders in primary care: randomised controlled trial and economic analysis Health Technology Assessment ·Andrew J. Vickers, Rowland Rees, Catherine Zollman, R McCarney, Claire Smith, Nadia Ellis, PAG Fisher, Robbert van Haselen, David Wonderling, Richard Grieve	2004	73
17	A systematic review of the role of bisphosphonates in metastatic disease Health Technology Assessment ·J R Ross, Y Saunders, Peter J. Edmonds, S Patel, David Wonderling, Camilla Normand, Karen Broadley	2004	387
18	Comparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screening Journal of Public Health ·Dalya Marks, Margaret Thorogood, H. A. W. Neil, David Wonderling, Steve E. Humphries	2003	28
19	Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation Statistics in Medicine ·Andrew Briggs, Christopher Z. Mooney, David Wonderling	1999	106
20	Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study BMJ ·David Wonderling, Constance L. McDermott, Martin Buxton, A L Kinmonth, S Pyke, Simon G. Thompson, David Wood	1996	46

About David Wonderling

David Wonderling is a scholar working on Geriatrics and Gerontology, Internal Medicine, Economics and Econometrics, Complementary and alternative medicine and Family Practice, having authored 47 papers that have together received 3.1k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (15 papers), Healthcare cost, quality, practices (5 papers), Clinical practice guidelines implementation (5 papers), Pancreatitis Pathology and Treatment (4 papers), Complementary and Alternative Medicine Studies (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Pharmaceutical Practices and Patient Outcomes (3 papers) and Diabetes Management and Research (3 papers). The work is most often cited by research in Geriatrics and Gerontology (125 citations), Economics and Econometrics (724 citations), Complementary and alternative medicine (193 citations), Internal Medicine (84 citations) and Cardiology and Cardiovascular Medicine (464 citations). David Wonderling has collaborated with scholars based in United Kingdom, United States and Egypt. Frequent co-authors include Andrew Briggs, Christopher Z. Mooney, Richard Grieve, Camilla Normand, Y Saunders, J R Ross, Peter J. Edmonds, Karen Broadley, Richard M. Nixon and Dalya Marks. Their work appears in journals such as Health Technology Assessment, Value in Health, BMJ, Gastroenterology and Health Economics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact